Skip to main content
Midas Edge

Bone Biologics Corp

For the period ended Dec 31, 2025. Filed Mar 2, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 2, 2026

BBLG$0.33+3.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Financial Statements and Supplementary Data

Item 8.Financial Statements and Supplementary Data

The financial statements and supplementary data required by Regulation S-X are included in Item 15. “Exhibits and Financial Statements Schedules” contained in Part IV, Item 15 of this Annual Report.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.